Psychemedics PE Ratio 2012-2024 | PMD
Current and historical p/e ratio for Psychemedics (PMD) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Psychemedics PE ratio as of September 16, 2026 is 0.00.
| Psychemedics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-12-12 | 2.67 | 0.00 | |
| 2024-12-31 | 2.67 | $-0.32 | 0.00 |
| 2024-09-30 | 2.31 | $-0.51 | 0.00 |
| 2024-06-30 | 2.42 | $-0.78 | 0.00 |
| 2024-03-31 | 2.93 | $-0.77 | 0.00 |
| 2023-12-31 | 2.96 | $-0.72 | 0.00 |
| 2023-09-30 | 3.97 | $-0.68 | 0.00 |
| 2023-06-30 | 4.56 | $-0.34 | 0.00 |
| 2023-03-31 | 5.18 | $-0.27 | 0.00 |
| 2022-12-31 | 4.77 | $-0.19 | 0.00 |
| 2022-09-30 | 6.20 | $-0.35 | 0.00 |
| 2022-06-30 | 6.03 | $-0.20 | 0.00 |
| 2022-03-31 | 6.49 | $-0.12 | 0.00 |
| 2021-12-31 | 6.60 | $-0.12 | 0.00 |
| 2021-09-30 | 7.85 | $0.06 | 130.78 |
| 2021-06-30 | 6.50 | $-0.27 | 0.00 |
| 2021-03-31 | 5.79 | $-0.66 | 0.00 |
| 2020-12-31 | 4.75 | $-0.70 | 0.00 |
| 2020-09-30 | 4.12 | $-0.69 | 0.00 |
| 2020-06-30 | 5.18 | $-0.37 | 0.00 |
| 2020-03-31 | 5.65 | $0.14 | 40.37 |
| 2019-12-31 | 8.38 | $0.28 | 29.93 |
| 2019-09-30 | 8.19 | $0.53 | 15.45 |
| 2019-06-30 | 8.87 | $0.64 | 13.87 |
| 2019-03-31 | 12.13 | $0.71 | 17.08 |
| 2018-12-31 | 13.56 | $0.83 | 16.33 |
| 2018-09-30 | 15.90 | $1.09 | 14.59 |
| 2018-06-30 | 16.13 | $1.11 | 14.53 |
| 2018-03-31 | 17.75 | $1.06 | 16.75 |
| 2017-12-31 | 16.97 | $1.10 | 15.42 |
| 2017-09-30 | 15.08 | $1.11 | 13.59 |
| 2017-06-30 | 20.27 | $1.35 | 15.01 |
| 2017-03-31 | 16.16 | $1.49 | 10.85 |
| 2016-12-31 | 19.76 | $1.22 | 16.20 |
| 2016-09-30 | 15.76 | $0.82 | 19.22 |
| 2016-06-30 | 10.84 | $0.48 | 22.59 |
| 2016-03-31 | 10.74 | $0.23 | 46.69 |
| 2015-12-31 | 7.82 | $0.28 | 27.93 |
| 2015-09-30 | 7.65 | $0.38 | 20.13 |
| 2015-06-30 | 11.14 | $0.40 | 27.85 |
| 2015-03-31 | 12.34 | $0.51 | 24.21 |
| 2014-12-31 | 11.17 | $0.60 | 18.62 |
| 2014-09-30 | 10.33 | $0.63 | 16.40 |
| 2014-06-30 | 10.22 | $0.66 | 15.49 |
| 2014-03-31 | 12.25 | $0.70 | 17.50 |
| 2013-12-31 | 10.42 | $0.72 | 14.47 |
| 2013-09-30 | 9.30 | $0.61 | 15.24 |
| 2013-06-30 | 7.45 | $0.58 | 12.85 |
| 2013-03-31 | 8.17 | $0.57 | 14.33 |
| 2012-12-31 | 7.27 | $0.57 | 12.75 |
| 2012-09-30 | 8.05 | $0.61 | 13.20 |
| 2012-06-30 | 6.78 | $0.65 | 10.43 |
| 2012-03-31 | 6.37 | $0.67 | 9.51 |
| 2011-12-31 | 5.82 | $0.67 | 8.68 |
| 2011-09-30 | 4.50 | $0.65 | 6.92 |
| 2011-06-30 | 5.92 | $0.60 | 9.87 |
| 2011-03-31 | 6.80 | $0.56 | 12.15 |
| 2010-12-31 | 4.98 | $0.50 | 9.96 |
| 2010-09-30 | 5.58 | $0.53 | 10.52 |
| 2010-06-30 | 4.72 | $0.52 | 9.07 |
| 2010-03-31 | 4.48 | $0.38 | 11.80 |
| 2009-12-31 | 4.22 | $0.29 | 14.55 |
| 2009-09-30 | 3.49 | $0.22 | 15.87 |
| 2009-06-30 | 3.80 | $0.24 | 15.85 |
| 2009-03-31 | 3.07 | $0.41 | 7.49 |
| 2008-12-31 | 3.37 | $0.57 | 5.91 |
| 2008-09-30 | 6.97 | $0.71 | 9.82 |
| 2008-06-30 | 7.69 | $0.77 | 9.99 |
| 2008-03-31 | 8.26 | $0.82 | 10.07 |
| 2007-12-31 | 7.38 | $0.85 | 8.68 |
| 2007-09-30 | 7.87 | $0.90 | 8.74 |
| 2007-06-30 | 9.23 | $0.94 | 9.82 |
| 2007-03-31 | 7.58 | $0.96 | 7.89 |
| 2006-12-31 | 8.56 | $0.94 | 9.11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.020B |
| Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |